Global Platinum-based Anticancer APIs Market Research Report 2021

1 Platinum-based Anticancer APIs Market Overview

• 1.1 Product Overview and Scope of Platinum-based Anticancer APIs
• 1.2 Platinum-based Anticancer APIs Segment by Type
  • 1.2.1 Global Platinum-based Anticancer APIs Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Cisplatin
  • 1.2.3 Carboplatin
  • 1.2.4 Oxaliplatin
  • 1.2.5 Nedaplatin
  • 1.2.6 Others
• 1.3 Platinum-based Anticancer APIs Segment by Application
  • 1.3.1 Global Platinum-based Anticancer APIs Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Testicular Cancer
  • 1.3.3 Osteosarcoma
  • 1.3.4 Breast Cancer
  • 1.3.5 Esophageal Cancer
  • 1.3.6 NSCLC
  • 1.3.7 Other
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Platinum-based Anticancer APIs Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Platinum-based Anticancer APIs Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Platinum-based Anticancer APIs Production Estimates and Forecasts (2016-2027)
• 1.5 Global Platinum-based Anticancer APIs Market by Region
  • 1.5.1 Global Platinum-based Anticancer APIs Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)
  • 1.5.5 China Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)
  • 1.5.5 India Platinum-based Anticancer APIs Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Platinum-based Anticancer APIs Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Platinum-based Anticancer APIs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Platinum-based Anticancer APIs Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Platinum-based Anticancer APIs Production Sites, Area Served, Product Types
• 2.6 Platinum-based Anticancer APIs Market Competitive Situation and Trends
  • 2.6.1 Platinum-based Anticancer APIs Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Platinum-based Anticancer APIs Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Platinum-based Anticancer APIs Market Share by Region (2016-2021)
• 3.2 Global Platinum-based Anticancer APIs Revenue Market Share by Region (2016-2021)
• 3.3 Global Platinum-based Anticancer APIs Production, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Platinum-based Anticancer APIs Production
  • 3.4.1 North America Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
  • 3.4.2 North America Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Platinum-based Anticancer APIs Production
  • 3.5.1 Europe Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
  • 3.5.2 Europe Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Platinum-based Anticancer APIs Production
  • 3.6.1 China Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
  • 3.6.2 China Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 India Platinum-based Anticancer APIs Production
  • 3.7.1 India Platinum-based Anticancer APIs Production Growth Rate (2016-2021)
  • 3.7.2 India Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Platinum-based Anticancer APIs Consumption by Region

• 4.1 Global Platinum-based Anticancer APIs Consumption by Region
  • 4.1.1 Global Platinum-based Anticancer APIs Consumption by Region
  • 4.1.2 Global Platinum-based Anticancer APIs Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Platinum-based Anticancer APIs Consumption by Country
  • 4.2.2 U.S.
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Platinum-based Anticancer APIs Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Platinum-based Anticancer APIs Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Platinum-based Anticancer APIs Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Platinum-based Anticancer APIs Production Market Share by Type (2016-2021)
• 5.2 Global Platinum-based Anticancer APIs Revenue Market Share by Type (2016-2021)
• 5.3 Global Platinum-based Anticancer APIs Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Platinum-based Anticancer APIs Consumption Market Share by Application (2016-2021)
• 6.2 Global Platinum-based Anticancer APIs Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 Jiangsu Hengrui Medicine
  • 7.1.1 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Corporation Information
  • 7.1.2 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Portfolio
  • 7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 Jiangsu Hengrui Medicine Main Business and Markets Served
  • 7.1.5 Jiangsu Hengrui Medicine Recent Developments/Updates
• 7.2 Nanjing Pharmaceutical Factory
  • 7.2.1 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Corporation Information
  • 7.2.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Portfolio
  • 7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 Nanjing Pharmaceutical Factory Main Business and Markets Served
  • 7.2.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
• 7.3 Qilu Pharmaceutical
  • 7.3.1 Qilu Pharmaceutical Platinum-based Anticancer APIs Corporation Information
  • 7.3.2 Qilu Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
  • 7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Qilu Pharmaceutical Main Business and Markets Served
  • 7.3.5 Qilu Pharmaceutical Recent Developments/Updates
• 7.4 Neptunus
  • 7.4.1 Neptunus Platinum-based Anticancer APIs Corporation Information
  • 7.4.2 Neptunus Platinum-based Anticancer APIs Product Portfolio
  • 7.4.3 Neptunus Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Neptunus Main Business and Markets Served
  • 7.4.5 Neptunus Recent Developments/Updates
• 7.5 Hisun
  • 7.5.1 Hisun Platinum-based Anticancer APIs Corporation Information
  • 7.5.2 Hisun Platinum-based Anticancer APIs Product Portfolio
  • 7.5.3 Hisun Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 Hisun Main Business and Markets Served
  • 7.5.5 Hisun Recent Developments/Updates
• 7.6 Jiangsu HaiCi biological pharmaceutical
  • 7.6.1 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Corporation Information
  • 7.6.2 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Portfolio
  • 7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Jiangsu HaiCi biological pharmaceutical Main Business and Markets Served
  • 7.6.5 Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates
• 7.7 Kunming Guiyan Pharmaceutical
  • 7.7.1 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Corporation Information
  • 7.7.2 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
  • 7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Kunming Guiyan Pharmaceutical Main Business and Markets Served
  • 7.7.5 Kunming Guiyan Pharmaceutical Recent Developments/Updates
• 7.8 Lingnan Pharmacy
  • 7.8.1 Lingnan Pharmacy Platinum-based Anticancer APIs Corporation Information
  • 7.8.2 Lingnan Pharmacy Platinum-based Anticancer APIs Product Portfolio
  • 7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Lingnan Pharmacy Main Business and Markets Served
  • 7.7.5 Lingnan Pharmacy Recent Developments/Updates
• 7.9 Jinzhou Jiutai Pharmaceutical
  • 7.9.1 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Corporation Information
  • 7.9.2 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
  • 7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Jinzhou Jiutai Pharmaceutical Main Business and Markets Served
  • 7.9.5 Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
• 7.10 Nanjing Hairun Pharmaceutical
  • 7.10.1 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Corporation Information
  • 7.10.2 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
  • 7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.10.4 Nanjing Hairun Pharmaceutical Main Business and Markets Served
  • 7.10.5 Nanjing Hairun Pharmaceutical Recent Developments/Updates
• 7.11 Simcere
  • 7.11.1 Simcere Platinum-based Anticancer APIs Corporation Information
  • 7.11.2 Simcere Platinum-based Anticancer APIs Product Portfolio
  • 7.11.3 Simcere Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.11.4 Simcere Main Business and Markets Served
  • 7.11.5 Simcere Recent Developments/Updates
• 7.12 Teva
  • 7.12.1 Teva Platinum-based Anticancer APIs Corporation Information
  • 7.12.2 Teva Platinum-based Anticancer APIs Product Portfolio
  • 7.12.3 Teva Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.12.4 Teva Main Business and Markets Served
  • 7.12.5 Teva Recent Developments/Updates
• 7.13 Cipla
  • 7.13.1 Cipla Platinum-based Anticancer APIs Corporation Information
  • 7.13.2 Cipla Platinum-based Anticancer APIs Product Portfolio
  • 7.13.3 Cipla Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.13.4 Cipla Main Business and Markets Served
  • 7.13.5 Cipla Recent Developments/Updates
• 7.14 Heraeus
  • 7.14.1 Heraeus Platinum-based Anticancer APIs Corporation Information
  • 7.14.2 Heraeus Platinum-based Anticancer APIs Product Portfolio
  • 7.14.3 Heraeus Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.14.4 Heraeus Main Business and Markets Served
  • 7.14.5 Heraeus Recent Developments/Updates
• 7.15 Hospira(Pfizer)
  • 7.15.1 Hospira(Pfizer) Platinum-based Anticancer APIs Corporation Information
  • 7.15.2 Hospira(Pfizer) Platinum-based Anticancer APIs Product Portfolio
  • 7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.15.4 Hospira(Pfizer) Main Business and Markets Served
  • 7.15.5 Hospira(Pfizer) Recent Developments/Updates
• 7.16 Taj Pharmaceuticals
  • 7.16.1 Taj Pharmaceuticals Platinum-based Anticancer APIs Corporation Information
  • 7.16.2 Taj Pharmaceuticals Platinum-based Anticancer APIs Product Portfolio
  • 7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.16.4 Taj Pharmaceuticals Main Business and Markets Served
  • 7.16.5 Taj Pharmaceuticals Recent Developments/Updates
• 7.17 Umicore Precious Metals Chemistry
  • 7.17.1 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Corporation Information
  • 7.17.2 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Portfolio
  • 7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.17.4 Umicore Precious Metals Chemistry Main Business and Markets Served
  • 7.17.5 Umicore Precious Metals Chemistry Recent Developments/Updates

8 Platinum-based Anticancer APIs Manufacturing Cost Analysis

• 8.1 Platinum-based Anticancer APIs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Platinum-based Anticancer APIs
• 8.4 Platinum-based Anticancer APIs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Platinum-based Anticancer APIs Distributors List
• 9.3 Platinum-based Anticancer APIs Customers

10 Market Dynamics

• 10.1 Platinum-based Anticancer APIs Industry Trends
• 10.2 Platinum-based Anticancer APIs Growth Drivers
• 10.3 Platinum-based Anticancer APIs Market Challenges
• 10.4 Platinum-based Anticancer APIs Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Platinum-based Anticancer APIs by Region (2022-2027)
• 11.2 North America Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)
• 11.3 Europe Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)
• 11.4 China Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)
• 11.5 India Platinum-based Anticancer APIs Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Platinum-based Anticancer APIs
• 12.2 North America Forecasted Consumption of Platinum-based Anticancer APIs by Country
• 12.3 Europe Market Forecasted Consumption of Platinum-based Anticancer APIs by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Platinum-based Anticancer APIs by Region
• 12.5 Latin America Forecasted Consumption of Platinum-based Anticancer APIs by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Platinum-based Anticancer APIs by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Platinum-based Anticancer APIs by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Platinum-based Anticancer APIs by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Platinum-based Anticancer APIs by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List